Dexlansoprazole

Antipeptic Ulcerant · Proton pump inhibitor

Indications

Short term (4 weeks) treatment of heart burn associative with non-erosive GERD, short term (up to 8 weeks) treatment of all grades of erosive oesophagitis; to maintain healing of erosive oesophagitis and relief of heart burn for up to 6 months.

Dosage

Adults: Erosive oesophagitis (EE): Short term treatment: 60 mg once daily for up to 8 wk. Maintenance of healed EE and symptomatic relief of heartburn: 30 mg once daily up to 6 mth. Symptomatic GERD: Short term treatment: 30 mg once daily for up to 6 mth. Children: Not recommended.

Adverse Effects

Nausea, vomiting, rash, hives, itching, difficulty breathing or swallowing. Irregular, fast, or pounding heartbeat, excessive tiredness, dizziness, lightheadedness, muscle spasms, uncontrollable shaking of a part of the body, seizures, severe diarrhoea with watery stools, stomach pain and fever.

Risk Factor (Pregnancy/Lactation)

Pregnancy: No evidence of risk in humans. Lactation: Caution advised or effect undetermined. Precautions: Exclude malignancy before and during treatment. Severe hepatic impairment. Allergic to any ingredient in dexlansoprazole delayed-release capsules.

Interactions

Diuretics (e.g. furosemide, hydrochlorothiazide) because the risk of low blood magnesium levels may be increased. Anticoagulants (e.g. warfarin), digoxin, methotrexate, saquinavir, or tacrolimus because the risk of their side effects may be increased by dexlansoprazole delayed-release capsules. Ampicillin, atazanavir, bosutinib, clopidogrel, dasatinib, erlotinib, indinavir, iron, itraconazole, ketoconazole, mycophenolate, nelfinavir, nilotinib, posaconazole, rilpivirine, or sorafenib because their effectiveness may be decreased by dexlansoprazole delayed-release capsules.

Advice to Patient

Take with or without meals. Do not chew or swallow whole. If there is difficulty in swallowing, open the capsule and mix all contents in a tablespoon of applesauce. Swallow immediately without chewing. Granules may also be dispersed in 20 mL of water. The dispersion may be taken via an oral syringe or a nasogastric tube.

Pharmacokinetics

Absorption: Directly proportional to increase in dose. Metabolism: Hepatic. Half-life elimination: 1-2 hrs. Time to peak, serum: There are 2 distinct peaks. First peak: 1-2 hrs. Second peak: 4-5 hrs. Excretion: Urine. Faeces.

Brands with this active ingredient

• Bifasic
• Biozodex
• D-lansup
• D-lazol
• Daplazole
• Daxila
• Daxolanz
• DDR
• Delanzo
• Dex Dex
• Dexavis
• Dexcell DDR
• Dexiva
• Dexlan
• Dexlap

Compiled by Healify Pharmacy from published drug references. How we compile it →

Always consult a pharmacist or doctor.